Results 221 to 230 of about 2,995,797 (334)

Influence of Systemically Administered Cortisone on Hair Growth in Mice11From the Departments of Dermatology and Syphilology, New York University Post-Graduate Medical School and New York University School of Medicine (Dr. Marion B. Sulzberger, Chairman) and the Skin and Cancer Unit of University Hospital, New York 3, N.Y.This investigation was supported by Grant DA-49-007-MD-753 from the Research and Development Division, Department of the U.S. Army and by Grant C-3756 from the U.S. Public …

, 1961
S.D. Morrill, Franz Herrmann
openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Preclinical Models for Functional Precision Lung Cancer Research. [PDF]

Cancers (Basel)
Yu JZ, Kiss Z, Ma W, Liang R, Li T.
europepmc   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Olivia Newton-John Cancer Research Institute 10-year Anniversary Conference - a decade of discovery and translation. [PDF]

Cell Death Dis
Eljammas K, Li TA, Neil L, Nightingale R, El-Saafin F, Berthelet J, Mielke LA, Pal B.   +7 more
europepmc   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

A scoping review of OMOP CDM adoption for cancer research using real world data. [PDF]

NPJ Digit Med
Wang L, Wen A, Fu S, Ruan X, Huang M, Li R, Lu Q, Lyu H, Williams AE, Liu H.   +9 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Transforming Cancer Research through Informatics. [PDF]

Cancer Discov
Klemm JD, Singer DS, Mesirov JP.
europepmc   +1 more source

Russian Cancer Research

, 1969
Robert J. Harris
openalex   +1 more source